High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy
Jay D. Raman(Penn State Milton S. Hershey Medical Center), Stephen A. Boorjian(Mayo Clinic), Mark S. Hockenberry(University of Pennsylvania), Jay Simhan(Fox Chase Cancer Center), Matthew Kaag(Penn State Milton S. Hershey Medical Center), Timothy Atkinson(University of Kentucky), Douglas S. Scherr(Cornell University), Karim Bensalah(Centre Hospitalier Universitaire de Rennes), Mark Wille(University of Chicago), Shahrokh F. Shariat(Universitätszahnklinik Wien), B. Peyronnet(Centre Hospitalier Universitaire de Rennes), Alexander Kutikov(Fox Chase Cancer Center), Yu-Kuan Lin(Penn State Milton S. Hershey Medical Center), Michael Herman(Borland Groover Clinic), Thomas J. Guzzo(Hospital of the University of Pennsylvania), Norm D. Smith(Caris Life Sciences (United States)), Paul L. Crispen(University of Kentucky)
Cited by 71
Related Papers
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|381
Transfusion guidelines for neonates and older children
|British Journal of Haematology|2004|371
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
|The Journal of Urology|2012|359
Expression of Neutrophil Collagenase (Matrix Metalloproteinase-8) in Human Atheroma
|Circulation|2001|347